Gabriella Hsia

Ms. Gabriella Hsia

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in Stem Cells International
Verified
Journal Article
Open access
PDF file
GHGabriella Hsia
Gabriella Hsia
JEJoyce Esposito
Joyce Esposito
LRLetícia Alves da Rocha
Letícia Alves da Rocha
SRSofia Lígia Guimarães Ramos
Sofia Lígia Guimarães Ramos
OOOswaldo Keith Okamoto
Oswaldo Keith Okamoto
Transplantation is essential and crucial for individuals suffering from end-stage organ failure diseases. However, there are still many challenges regarding these procedures, such as high rates of organ rejection, shortage of organ donors, and long waiting lines. Thus, investments and efforts to develop laboratory-grown organs have increased over the past years, and with the recent progress in regenerative medicine, growing organs in vitro might be a reality within the next decades. One of the many different strategies to address this issue relies on organoid technology, a miniaturized and simplified version of an organ. Here, we address recent progress on organoid research, focusing on transplantation of intestine, retina, kidney, liver, pancreas, brain, lung, and heart organoids. Also, we discuss the main outcomes after organoid transplantation, common challenges faced by these promising regenerative medicine approaches, and future perspectives on the field.

3 August 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
GKGerson Kobayashi
Gerson Kobayashi
LBLuciano Brito
Luciano Brito
DMDanielle de Paula Moreira
Danielle de Paula Moreira
ASAngela May Suzuki
Angela May Suzuki
GHGabriella Hsia
Gabriella Hsia
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
Rapid diagnostics is pivotal to curb SARS-CoV-2 transmission, and saliva has emerged as a practical alternative to naso/oropharyngeal (NOP) specimens. We aimed to develop a direct RT-LAMP (reverse transcription loop-mediated isothermal amplification) workflow for viral detection in saliva, and to provide more information regarding its potential in curbing COVID-19 transmission. Clinical and contrived specimens were used to optimize formulations and sample processing protocols. Salivary viral load was determined in symptomatic patients to evaluate the clinical performance of the test and to characterize saliva based on age, gender and time from onset of symptoms. Our workflow achieved an overall sensitivity of 77.2% (n = 90), with 93.2% sensitivity, 97% specificity, and 0.895 Kappa for specimens containing >102 copies/μL (n = 77). Further analyses in saliva showed that viral load peaks in the first days of symptoms and decreases afterwards, and that viral load is ~10 times lower in females compared to males, and declines following symptom onset. NOP RT-PCR data did not yield relevant associations. This work suggests that saliva reflects the transmission dynamics better than NOP specimens, and reveals gender differences that may reflect higher transmission by males. This saliva RT-LAMP workflow can be applied to track viral spread and, to maximize detection, testing should be performed immediately after symptoms are presented, especially in females.

7 November 2017 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
DBD.R. Bertola
D.R. Bertola
GHGabriella Hsia
Gabriella Hsia
LAL. Alvizi
L. Alvizi
AGA. Gardham
A. Gardham
EWE.L. Wakeling
E.L. Wakeling
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno

22 March 2017 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
VTVanessa L. Romanelli Tavares
Vanessa L. Romanelli Tavares
RZRoseli M. Zechi‐Ceide
Roseli M. Zechi‐Ceide
DBDebora R. Bertola
Debora R. Bertola
CGChristopher T. Gordon
Christopher T. Gordon
SFSimone G. Ferreira
Simone G. Ferreira
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno

16 July 2018 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
CMCarolina Malcher
Carolina Malcher
GYGuilherme L. Yamamoto
Guilherme L. Yamamoto
PBPhilip Burnham
Philip Burnham
SESuzana A.M. Ezquina
Suzana A.M. Ezquina
NLNaila C.V. Lourenço
Naila C.V. Lourenço
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
Our aim was to develop and apply a comprehensive noninvasive prenatal test (NIPT) by using high-coverage targeted next-generation sequencing to estimate fetal fraction, determine fetal sex, and detect trisomy and monogenic disease without parental genotype information. We analyzed 45 pregnancies, 40 mock samples, and eight mother-child pairs to generate 35 simulated datasets. Fetal fraction (FF) was estimated based on analysis of the single nucleotide polymorphism (SNP) allele fraction distribution. A Z-score was calculated for trisomy of chromosome 21 (T21), and fetal sex detection. Monogenic disease detection was performed through variant analysis. Model validation was performed using the simulated datasets. The novel model to estimate FF was robust and accurate (r2= 0.994, p-value < 2.2e-16). For samples with FF > 0.04, T21 detection had 100% sensitivity (95% CI: 63.06 to 100%) and 98.53% specificity (95% CI: 92.08 to 99.96%). Fetal sex was determined with 100% accuracy. We later performed a proof of concept for monogenic disease diagnosis of 5/7 skeletal dysplasia cases. In conclusion, it is feasible to perform a comprehensive NIPT by using only data from high coverage targeted sequencing, which, in addition to detecting trisomies, also make it possible to identify pathogenic variants of the candidate genes for monogenic diseases.

25 April 2018 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
GHGabriella Hsia
Gabriella Hsia
CMCamila M. Musso
Camila M. Musso
LALucas Alvizi
Lucas Alvizi
LBLuciano A. Brito
Luciano A. Brito
GKGerson Shigeru Kobayashi
Gerson Shigeru Kobayashi
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
Repeats in coding and non-coding regions have increasingly been associated with many human genetic disorders, such as Richieri-Costa-Pereira syndrome (RCPS). RCPS, mostly characterized by midline cleft mandible, Robin sequence and limb defects, is an autosomal-recessive acrofacial dysostosis mainly reported in Brazilian patients. This disorder is caused by decreased levels of EIF4A3, mostly due to an increased number of repeats at the EIF4A3 5′UTR. EIF4A3 5′UTR alleles are CG-rich and vary in size and organization of three types of motifs. An exclusive allelic pattern was identified among affected individuals, in which the CGCA-motif is the most prevalent, herein referred as “disease-associated CGCA-20nt motif.” The origin of the pathogenic alleles containing the disease-associated motif, as well as the functional effects of the 5′UTR motifs on EIF4A3 expression, to date, are entirely unknown. Here, we characterized 43 different EIF4A3 5′UTR alleles in a cohort of 380 unaffected individuals. We identified eight heterozygous unaffected individuals harboring the disease-associated CGCA-20nt motif and our haplotype analyses indicate that there are more than one haplotype associated with RCPS. The combined analysis of number, motif organization and haplotypic diversity, as well as the observation of two apparently distinct haplotypes associated with the disease-associated CGCA-20nt motif, suggest that the RCPS alleles might have arisen from independent unequal crossing-over events between ancient alleles at least twice. Moreover, we have shown that the number and sequence of motifs in the 5′UTR region is associated with EIF4A3 repression, which is not mediated by CpG methylation. In conclusion, this study has shown that the large number of repeats in EIF4A3 does not represent a dynamic mutation and RCPS can arise in any population harboring alleles with the CGCA-20nt motif. We also provided further evidence that EIF4A3 5′UTR is a regulatory region and the size and sequence type of the repeats at 5′UTR may contribute to clinical variability in RCPS.